"Moriggia-Pelascini" Hospital
Gravedona Ed Uniti, Como, 22015, Italy
NCT Number: NCT03015714
Evaluation of the effectiveness of aquatic therapy for the treatment of freezing of gait in Parkinson's disease patients undergoing a multidisciplinary and intensive rehabilitation treatment.
Looking for future studies?
Notify Me50 year–85 year
All sexes
Interventional
Not applicable
Gravedona Ed Uniti, Como, 22015, Italy
Freezing of gait (FoG) is an often dramatic, disabling episodic gait pattern that is common in Parkinson's disease (PD). FoG highly impairs mobility, causes falls, and reduces quality of life. Given the limited effectiveness of both the dopaminergic therapy and the deep brain stimulation on this symptom, it represents a challenge in the field of rehabilitation. In the last years, some studies described the effectiveness of aquatic therapy on balance dysfunction in patients with PD, correlating it to the safe conditions offered by the aquatic environment and to the physical properties of water. Nevertheless, the issues concerning the feasibility and the effectiveness of aquatic therapy for the treatment of FoG have never been addressed before. The aquatic environment may act on the sensorial peripheral receptors, thus widely stimulating the proprioceptive system. PD patients show an altered processing of the proprioceptive information that could potentially underline FoG. The investigators aim at investigating the effects of aquatic therapy for the treatment of FoG in PD patients undergoing a Multidisciplinary Intensive Rehabilitation Treatment (MIRT), whose effectiveness on several motor and functional parameters has been already demonstrated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MIRT consists of a 4-week rehabilitation program in a hospital setting, which entails four daily sessions of physical therapy for five days and one hour of physical exercise on the sixth day. On the seventh day the patient rests. The duration of each session, including recovery periods, is about one hour. The first session consists of a one-to-one session with a physical therapist. The second session includes aerobic exercises to improve balance and gait, using different devices: a stabilometric platform with visual cues, a treadmill plus and a cycloergometer. The third session consists of occupational therapy, the fourth one includes one hour of speech therapy.
Patients in the MIRT-AT group will undergo the land-based therapy described in MIRT plus three sessions per week (Monday, Wednesday, Friday) of aquatic therapy. On days of aquatic therapy the first session of MIRT was not provided. The aquatic therapy program included aerobic exercises and physical activities to improve balance, motor skills, coordination and joints mobility. The water sessions were divided into 3 phases: i) Warm Up Exercises, ii) Central session Training, iii) Cool-down.
Time frame: 4 weeks
Assess FoG frequency, disturbances in gait and relationship to clinical features conceptually associated with gait and motor aspects.
Time frame: 4 weeks
Clinician-scored monitored patient's global evaluation.
Time frame: 4 weeks
UPDRS subpart: clinician-scored monitored patient's motor evaluation
Time frame: 4 weeks
UPDRS subart: clinician-scored monitored patient's activitied daily life evaluation
Time frame: 4 weeks
Motor-functional test for balance evaluation
Time frame: 4 weeks
Motor-functional test for sit to stand, walking and turning evaluation
Time frame: 4 weeks
Motor-functional test for gait endurance
Ospedale Generale Di Zona Moriggia-Pelascini
Other
Effectiveness of Aquatic Therapy for Parkinson's Disease Patients in the Context of a Multidisciplinary, Intensive Rehabilitation Treatment
Acronym: AT-FOG
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05510739
Basal Ganglia Diseases, Behavior
Stockholm, Sweden
View Trial DetailsNCT05938673
Basal Ganglia Diseases, Brain Diseases
São Paulo, Brazil
View Trial DetailsNCT05110053
Basal Ganglia Diseases, Brain Diseases
Aarhus, Denmark
View Trial DetailsNCT03213873
Basal Ganglia Diseases, Behavior
Huddinge, Sweden
View Trial Details